GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development
Pharmaceuticals company is investing £400m in UK life sciences and moving scientists to new Cambridge R&D site Business live – latest updates The British drugmaker GSK is to announce sweeping job cuts as part of a £1.9bn cost-cutting programme to pay for a £400m investment in UK life sciences over the next three years, including in a new research and development centre in Cambridge, as it looks…
GlaxoSmithKline (GSK) plans to reduce staff numbers as part of a £1.9 billion cost-cutting initiative to fund a £400 million investment in UK life sciences. The pharmaceuticals company aims to accelerate drug development under its new chief executive. Over 1,000 scientists will relocate to a new research and development centre in Cambridge. The company will shut its R&D facility in Stevenage, Hertfordshire, by 2029, while upgrading laboratories in Ware and relocating some employees there.
Written by urgent.news from Guardian Science's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
